SailPoint stock sinks 6% today: what’s driving SAIL and what to watch next
2 January 2026
1 min read

SailPoint stock sinks 6% today: what’s driving SAIL and what to watch next

NEW YORK, Jan 2, 2026, 15:10 ET — Regular session

  • SailPoint shares were down about 6.5% in afternoon trading, underperforming several cybersecurity peers.
  • The slide came as investors started 2026 with a cautious tone toward growth stocks amid rate and data uncertainty.
  • Traders are watching key technical levels near $20 and the company’s next quarterly update later this quarter.

Shares of SailPoint, Inc. fell about 6.5% on Friday, giving the identity security software maker one of the sharpest declines among mid-cap cybersecurity stocks.

The drop matters because investors are opening the new year reassessing risk after 2025’s strong run, with attention shifting back to valuations and the interest-rate outlook that tends to drive high-growth software. 1

“Stocks trade expensive on 18 of 20 measures,” said Savita Subramanian, Bank of America’s equity and quant strategist, in a note, as investors looked ahead to next week’s labor-market data for clues on the Federal Reserve’s next steps. 1

SailPoint was trading at $18.91 after touching a session low of $18.81. The stock opened at $20.46 after closing at $20.23 on Thursday.

The selling was broader than one name. Okta was down about 3%, CyberArk fell about 2.6% and CrowdStrike slid roughly 3.5% in the same window.

The broader tape was mixed, with blue-chip shares firmer while tech lagged — a setup that often pressures smaller, higher-multiple software names.

SailPoint sells identity security software that helps companies manage and secure access to applications and data — essentially controlling “who can access what” across sprawling corporate systems. 2

The company returned to public markets in February 2025 after private-equity firm Thoma Bravo took it private in 2022, in a deal valued at about $6.12 billion. 3

In its most recent quarterly update, SailPoint reported annual recurring revenue, or ARR — a subscription metric that annualizes contracted recurring revenue — rose 28% year over year to $1.04 billion, while revenue climbed 20% to $282 million. 2

SailPoint also raised its fiscal 2026 outlook in that report, forecasting total revenue of $1.067 billion to $1.071 billion and adjusted earnings per share of $0.22 to $0.23. It guided for fourth-quarter revenue of $290 million to $294 million and adjusted EPS of $0.08 to $0.09. 2

With SailPoint’s fiscal year ending Jan. 31, investors are focusing on whether subscription growth and cash generation stay on track heading into the next earnings update. Market data providers list late-March dates for the next report. 4

For traders, the $20 area has become a near-term reference point after Friday’s slide, while the day’s low near $18.80 is the next level to watch if selling pressure persists.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Booking Holdings stock falls today as Wall Street wobbles to start 2026 — what’s driving BKNG
Previous Story

Booking Holdings stock falls today as Wall Street wobbles to start 2026 — what’s driving BKNG

AT&T stock slips today as 2026 kicks off; traders eye earnings and rates
Next Story

AT&T stock slips today as 2026 kicks off; traders eye earnings and rates

Go toTop